This long, sorry and tragic story has been repeated so many time with other pharmaceutical drugs over the last 80 years. Every patient who takes drugs are at risk, and are usually quite unaware.
The BBC documentary, aired on 9th November 2026, “Mums v Big Pharma”, is the BBC at it’s best. Indeed, everyone should watch this programme rather than read this article! But before you switch over please understand that what you will learn from the documentary, which is specifically about the epilepsy drug sodium valproate (Epilim), has been duplicated many, many times over during the last 80+ years.
To understand these repeating tragedies only the name of the drug needs to be changed. The process is the same. The history of sodium valproate, marketed as Epilim, is not a one-off tragedy. It saturates the history of pharmaceutical medicine, and many of the medical tragedies that have happened since we misplaced our trust in pharmaceutical-led medicine, including Thalidomide, Primodos, Vioxx, contaminated blood, and now social valproate; but also many, many others…..
The story of Epilim is outlined in the documentary and can be outlined in a number of distinct stages.
In 1972 sodium valproate was approved for the treatment of epilepsy and ADHD amidst the usual “magic bullet” / “wonder cure” hype that accompanies the introduction of new pharmaceutical drugs and vaccines.
Most drugs are introduced as medical breakthroughs that will “change our experience” of one disease or another. They are lauded by government and the mainstream media (including the BBC). In time their promise is rarely, if ever, realised. The media provides free advertising for the drug companies in this respect. It always seems willing to report drug company news releases verbatim, and certainly without providing detailed evidence of their safety.
Sodium valproate had been tested by the drug company, as they are obliged to do, and in this case they did report some of the ‘negative’ safety findings to the MHRA (the UK’s drug regulator), including information about possible malformation of the foetus in the womb.
The honesty of drug companies when reporting safety concerns about new drugs to national drug regulators can never be taken for granted. It proved not to be an issue in this case, but medical science and drug companies have a long history of dishonesty in the way they interpret test data, the openness and transparency in publishing the data, and the withholding of ‘negative’ information that might prevent drug approval by the regulators.
On top of this drug regulators have a poor record of checking and investigating the information drug companies provide to them. This becomes very clear when all banned or withdrawn pharmaceutical drugs over the last 80 years are considered in this regard. Each of the drugs listed here were approved, but eventually withdrawn because of approval was not thorough.
The MHRA ignored the safety warnings given to them by Sanofi, the drug company, and in 1972 it gave sodium valproate a full licence. In doing so it allowed another potentially dangerous drug to be prescribed to patients, one that could and did cause significant harm.
The primary task of the drug regulatory system is to protect the public from harmful pharmaceutical drugs. Yet they rarely refuse to licence a drug, and certainly none of the drugs eventually banned or withdrawn because of the safety record were refused a licence! Until the damage they caused could no longer be hidden from public view.
Regulatory bodies around the world are staffed by people who have worked in the pharmaceutical industry, and many of them seem to find their way back into well-paid jobs within the industry once they have served their time. There is a very clear and obvious ‘revolving door’ of personnel between regulator and industry which is anathema to proper, ethical regulation.
There has long been a strong belief that drug regulatory agencies are more interested in safeguarding the financial interests of the industry than the health of the patients they are supposed to protect.
As with all licenced drugs, Epilim was soon being prescribed to patients, including to pregnant women. Doctors, encouraged by the MHRA’s approval, and the promotional media media hype given to the drug, began to prescribe it. Most doctors would not have been aware of anything untoward at this time as they would not have been aware of the existence of the safety concerns that the drug regular had ignored.
Doctors have been described, sometimes unfairly, as glorified drug salesmen! In fact they have pressure from both sides to prescribe drugs. The drug companies want and expect doctors to prescribe drugs. And the media promotion of new drugs usually generates pressure on patients to demand the drugs. And the doctor him/herself, when consulting sick patients, also feel the need to prescribe - something.
In the early years of a drug doctors will not necessarily have information about drug safety beyond what they have been told by drug regulators, or read in scientific journals, both sources that have proven to be considerably less than trustworthy over the years.
Patients were certainly not told about safety concerns relating to Epilim by their doctors. Nor would it have been contained in the Patient Information Leaflets (PILs) that accompanies all drugs. Indeed, as far as sodium valproate is concerned, the BBC documentary questions whether there was a PIL available for this drug in its earlier years.
Patients, in the main, trust their doctors. They assume that they would never prescribe any drug that might be harmful. What too many patients do is to overestimate the extent that doctors actually know about the safety of the drugs they prescribe. And if doctors do not know, patients cannot be told. Doctors prescribe most pharma drugs in this way; and patients take them; in these tragedies neither are initially aware of safety information. Too often this information has been withheld by a corrupt regulatory system.
Then there is a medical climate that tends to underestimate the seriousness of drug side effects, and adverse reactions. “The benefits outweigh the disadvantages”. The drug is “well tolerated”. Then, when patients have taken the drug for a time, and suffer an adverse reaction, they do not attribute it to the drug. Similarly doctors have little incentive to tell patients that a drug they have prescribed to them might be causing them harm.
This leaves patients with much that they do know. They have limited ability or opportunity to argue and debate the pros and cons of a particular treatment with doctors who become increasingly defensive.
By the mid-1990’s sodium valproate (Epilim) had become one of the most widely prescribed drugs for epilepsy. It was prescribed to pregnant women, and to women in their child-bearing years. By this time the drug was lauded for its ability to control epilepsy. Yet there were growing concerns that implicated the drug with diseases like Autism, Spina Bifida, Cleft Pallet, and limb deformities. These concerns were discounted by the medical establishment. There was, critics were told, “insufficient statistical evidence”, “no direct proof of any link”. And in any case, if there was a problem, it was “rare”, and so “largely irrelevant”.
Popular drugs are the source of Pharmas extreme wealth. In the last 100+ years the pharmaceutical industry have become the wealthiest of all industries, bar none. Whilst the drugs are much lauded for their apparent effectiveness treating a condition for which they are prescribed, adverse drug effects become increasingly apparent.
And as serious adverse reactions increase, more patients begin to ask questions about the safety of these ‘ground breaking’ wonder drugs.
The drug companies, and the wider medical establishment, have to respond. And the medical response is usually denial, or deflection, or obfuscation. It is not just that the drug companies profit from drug sales, although this is an important factor. If doctors began to recognise the link between a drug and serious adverse reactions they would be admitting that they had prescribed an unsafe drug. The drug regulator has to justify why they approved it. And the media would have to explain why they promoted it. Not least, the drug company would have to justify whey they had produced and profited from it. None of this is good publicity. Professional reputations are at stake. Silence and denial are more comfortable responses.
So the medical establishment gets defensive. They discount the evidence against the drug. In denying responsibility medicine usually indicates that they expect patients, and perhaps a handful of ‘questioning’ doctors, to ‘prove’ that the drug had caused patient harm. So despite increasing concerns, patients are usually ignored, left to get on with the problems the drugs have caused, with little support or apparent understanding.
The BBC documentary is largely based on the testimony of several mums who had taken sodium valproate whilst pregnant, and had given birth to children who suffered harm as a result. Eventually they started a Patient Support Group, INFACT, the ‘Independent Fetal Anti-Convulsant Trust’. In this way a handful of mums quickly discovered that they were not the only victims of Epilim. There were thousands of them. The size of the problem grew as more and more parents came forward. However, the group received little official support from the medical establishment.
Patient Support Groups and Health Charities have the potential to do much good. However, the feature of most of these groups is that whilst they begin with good intentions they are quickly funded, and taken over by the pharmaceutical industry. The reason for this is that these groups are excellent conduits for drug companies to promote their treatments, and to generate charitable funds to develop new profitable drugs. This is why they are usually seen promoting drug-based medical treatments.
INFACT had no such pharmaceutical support. They, and groups like them, had challenged the safety of ‘popular’ drugs. They challenge the pharma industry, they seek to undermine public confidence in profitable drugs. They are not patient organisations that can be used to enhance drug sales, they actually threaten sales. And moreover they seek compensation for the damage a profitable drug had caused. So such groups find that they are crying in wilderness. To understand why this is we just have to “follow the money”.
By 2004 sodium valproate was making huge profits, an estimated annual turnover of £200 million, with about 50,000 women taking the drug. The pharmaceutical industry had a highly profitable drug to protect, and to do this they knew they had to deflect, and discount any criticism detrimental to sales.
Minor drugs facing this kind of opposition can be quickly ‘retired’ by the industry, the calculation being that if they are heavily criticised it is better to capitulate - especially if they have a replacement drug to offer.
But retiring a ‘popular’ money-generating drugs is different. Criticism then encourages drug companies to fight for its survival, and to do so for decades. The vast wealth of the pharmaceutical industry can be used to control the conventional medical establishment, including governments, medical science, drug regulators, and the mainstream media. This establishment represents a huge obstacle to any patient support group to challenge, however strong their case.
By 2009 the evidence against Epilim was described as “really clear”. The BBC documentary quoted: “Taking sodium valproate during pregnancy is now known to carry a 10% risk of major physical malformations, and a 30-40% risk of serious neurodevelopmental disorders including autism and ADHD”. It had taken nearly 40 years of serious drug harm to reach this point - even though a group of non-medical mums had arrived at this conclusion some 20 years earlier!
Most pharmaceutical drugs eventually reach this stage in their life cycle. Whilst drug companies are prepared to fight to the end, when ‘the end’ does come they have to admit defeat, and try to rein in their losses, and protect their reputation.
In 2011, when INFACT was planning legal action to compensate the families, the court withdrew their right to claim legal aid. How this came about is no doubt complex. But the machinations of the conventional medical establishment in this case led to serious obstacles being placed to restricts them. At the time the government was cutting expenditure in every part of public services, including legal aid. So INFACT lost out. They were now unable to pursue their claim through the courts as they did not have the money to pay the legal fees necessary to challenge the drug industry in court.
The Conventional Medical Establishment is immensely powerful. It includes both government (eager for industrial investment), and the mainstream media (including the BBC), eager for advertising revenue. Taking it on, as many groups supporting people harmed by pharmaceutical drugs do, is somewhere between difficult and impossible. It usually proves to be hard, if not impossible, to get their voice heard. There is public sympathy for those damaged by pharma drugs, but the public does not get to here about the issue.
By 2013, INFACT was still campaigning, negotiating with the MHRA in what they said was a highly defensive, unbudging and patronising way. They described in detail a lack of openness and honesty in their discussions so little progress was made. The situation had stalled. By this time sodium valproate had been prescribed for over 42 years, and an estimated 20,000 children had been exposed to it.
The conventional medical establishment always rigidly protects its interests, even when it has been firmly established that one of their drugs has caused serious patient harm. This impacts on two categories of patient. (i) Former patients who have already been harmed become increasingly frustrated by the prevarication of doctors and politicians. (ii) And patients who continue to be prescribed the offending drug, including new patients who will be prescribed the drug whilst no action is taken to stop it being prescribed.
Remember, by this stage, the medical establishment has had to accept that one of their drugs has caused serious patient harm. But ongoing inaction to often leads to yet more patient harm. The medical profession usually refuse to change their protocols as to do so might appear as an admission of previous error, and their culpability in any action taken against them.
For this reason the prescription of dangerous drugs often continues for many years. In a recent WDDTY article it was stated that an estimated 39,399 children in the UK had been exposed to sodium valproate. Note that the BBC documentary said that only 20,000 had been exposed to the drug up to 2013 (see above).
In 2015, the group discovered the devastating fact that Sinofi had actually told the MHRA about the negative test results that had arisen with the testing of sodium valproate before 1972. Correspondence was on record that animal testing had shown problems with both cancer and fetal malformation. One document, quoted in the documentary, recommended that “in women of child bearing age it should only be used in severe cases, or those resistant to other treatment”. One of the mums said, with little fear of contradiction, that the drug regulator had “hidden the findings purposely”.
The rules of drug testing had clearly been seriously broken. These rules had been in place following the tragedy of Thalidomide, a not dissimilar tragedy that developedin the 1970’s in much the same way as sodium valproate. So this was certainly not the first time that pharmaceutical medicine has breached the rules, and certainly not the last either!
INFACT’s discovery of these incriminating documents demonstrates one thing above all else. The drug regulatory system should operate for just one reason - to protect patients from harm. The system was designed so that patients, and thus their doctors, should have full and complete information about the drugs they are prescribed. Yet through the years patients have been routinely denied crucial information as a diect result of the machinations of a deeply flawed and inadequate system of drug regulation.
Too often vital information about pharmaceutical drugs and vaccines is found not to have been published; or had been effectively hidden. So patients are unable to make an informed choice about their treatment, and the benefits and disadvantages of taking particular drugs. This is the case for most, if not all drugs that are being prescribed to patients today.
So INFACT had won their battle. There was an admission by government that this was so. Two enquires were established, the Cumberlege Report in 2020, that recommended the NHS issued a public apology to the women, especially as had been aware of the birth defect risk yet still allowed the drug to be prescribed. The Hughes Report followed in 2024, proposing a two-stage financial and non-financial redress scheme for the families who had been harmed by sodium valproate.
So a compensation scheme was agreed. Yet two years after Hughes no money had been received by victims. In other similar cases patients and families have had similar lengthy waits to receive compensation.
The BBC documentary concludes with a long, vacuous, and utterly meaningless response from the government. It has become a typical form of words, empty talk, full of jargon and vague apologies and reassurances. Please, do read it!
So sodium valproate is yet another scandal arising from the failed medical drug. And it is NOT a one-off. Similar events have happened countless times before. It follows closely a well-known pattern > medical breakthrough > raised patient hopes and expectations for effective medical treatment > serious side-effects and adverse reactions > medical denials > the official discounting of the seriousness of the harm caused > reluctance to address the issues created by those tasked with solutions.
I first wrote about Sodium Valproate in 2010, "Epilim; a dangerous drug, but no legal redress for families", then in February 2013, "FACs. Fetal Anti-Convulsant Syndrome. A disease created by Big Pharma drugs?, then in April 2018, "Epilepsy. Another drug is banned - after being 'widely prescribed' for over 50 years", and in April 2022, "Sodium Valproate. The demise of another pharmaceutical drug. 20,000 damaged children? A tragedy worse than Thalidomide?"So the problems associated with this drug have been well known long before the current publicity of the scandal.
In future there is really only two solutions to these ongoing scandals. One is that the Conventional Medical Establishment should seriously reform itself in a way that genuinely recognises the dangers of pharmaceutical drugs and vaccines, and the serious harm they can do to our health. This seems unlikely to happen as there appears to be an almost complete lack of self-awareness within the medical hierarchy, and an unwillingness of government, and the mainstream media, to address the issue of iatrogenic disease full on.
The other solution is for each of patients to take action to protect themselves, for everyone to demand full disclosure of potential and actual safety issues in any medical treatment, and to refuse to engage with conventional medicine until we are certain that this has happened.
Many people, including myself, have already abandoned conventional, drug-based medicine. More people now focus on maintaining their health through diet, exercise, the removal of stress, thereby supporting the immune system. We rely on our innate immune system to protect us from illness.
And if we become ill we prefer to turn to alternative medical therapies. I have used homeopathy for the last 50 years, and doing so have been able to avoid falling into the tragedies of Thalidomide, Primodos, Vioxx, contaminated blood, and social valproate, and many others.
